Error message

The page you requested does not exist. For your convenience, a search was performed using the query events tue 23 jul 1100 lmb seminar series antibodies against ebola lassa global collaboration.

Search results

  1. Dr Catherine Lindon

    ... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...

  2. Dr Athena Matakidou

    ... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...

  3. Dr Mariann Bienz

    ... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...

  4. Dr Dario Bressan

    ... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...

  5. Dr Frank McCaughan

    My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...

  6. Professor Gillian Murphy

    ... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...

  7. Dr James Nathan

    Cellular mechanisms of oxygen and metabolite sensing: ...

  8. Dr James Rudd

    ... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...

  9. Ms Paola Marco

    ... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...

  10. Dr Marisa Segal

    ... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...

  11. Professor Simon Mendez-Ferrer

    The Méndez-Ferrer laboratory research focuses on the regulation of the haematopoietic stem-cell niche in health and disease. Blood stem cells reside in specialised niches which allows them to self-renew, proliferate, differentiate and migrate according...

  12. Mr Aws Al-deka

  13. Professor Antonis Antoniou

    My main research interest is the development and application of statistical modelling techniques for addressing clinical questions, and the development of risk prediction tools which are used in clinical practice. ...

  14. Dr Andrea Degasperi

  15. Miss Aristi Damaskou

  16. Miss Alicia Garcia Gimenez

  17. Professor Andrew Flewitt

    I work in large area electronics and MEMS devices, with a particular focus on acoustic wave devices using thin film piezoelectrics. There are two applications of these. Surface acoustic wave (SAW) devices can be used to make microfluidic pumps without...

  18. Miss Anne Babbage

  19. Professor Anna Korhonen

    I conduct research in computer science - in natural language processing and text mining. I have research projects which focus on biomedical text processing and mining, e.g. the CRAB and LION projects which develops text mining technology for the needs...

  20. Mr Alex Frankell

    Interpretation of Genomic data to inform in vitro molecular analysis and identify important drivers of Oesophageal adenocarcinoma carcinogenesis and Barrett's oesophageal progression. My project focuses on genomic aberrations in the Transforming growth...

  21. Mr Angelos Kolias

    Angelos Kolias is a Clinical Senior Lecturer and Consultant Neurosurgeon in the Department of Clinical Neurosciences, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University,...

  22. Professor Julie Ahringer

    We investigate the functions chromatin regulatory complexes implicated in human disease using the C. elegans model system. These include the histone deacetylase complex NuRD, the Retinoblastoma complex DRM, and a TIP60 histone acetyltransferase complex....

  23. Mr Julius Christopher Baeck

    I am a Wellcome Trust-funded  PhD student  in Klaus Okkenhaug's lab, Department of Pathology, University of Cambridge. My research focuses on the role of the lipid signalling kinase PI3K δ in B cell homoeostasis. I am particularly...

  24. Dr Julia Carmona-Bozo

    My study focuses on imaging Breast cancer by using PET-MRI

  25. Dr Julian Sale

    My lab is interested in the mechanisms that alleviate arrested DNA replication and the impact their loss has on mutagenesis and on the maintenance of epigenetic memory through the recycling of histones during replication. Replication can be arrested by...

  26. Dr Julius Mieszczanek

  27. Dr Julia Wilson

    Cambridge Cancer Centre Executive Committee, Associate Director for Genetics and Genomics

  28. Miss Julia Knight

    Various projects for Lung Cancer research. Main project working on is Mesobank, preforming the quality control for solid tissue collected.

  29. Dr Julia Moreno-Vicente

  30. Miss Júlia Ponte

  31. Dr Juliane Perner

    Application of computational biology approaches to integrate different types of 'omics'-data with a focus on improving our understanding of the molecular biology of Esophageal cancer and Barrett's esophagus.

  32. Dr Roy Rabbie

    We use DNA sequencing of patients and their tumours to study genomic evolution in melanoma.

  33. Dr John Lizhe Zhuang

    ... that initiate BO and OAC. Firstly, I have established a series of patient derided organoid models from normal tissues, BO, and OAC, and ...

  34. Professor Ming-Qing Du

    ... and molecular investigations. We have been undertaking a series of research programmes to elucidate the pathology, immunophenotype, and ...

  35. Dr Cedric Ghevaert

    ... in 2005. He obtained his PhD in 2008 studying novel antibodies for the treatment of bleeding in neonates in Cambridge. He obtained ...

  36. Dr Claudia Ribeiro de Almeida

    ... cells of the immune system responsible for the production of antibodies, and do so by employing hazardous mechanisms of somatic DNA mutation ...

  37. Dr Anna Git

    Non coding RNAs in breast cancer; Early detection of paraneoplastic autoantibodies.

  38. Miss Samantha Hallawell

    ... Immunotherapy- In vitro profiling of immunostimulatory antibodies as well as elucidation of antibody efficacy and target rationale ...

  39. Dr Michael Dyson

    ... aims to generate and functionally validate recombinant antibodies to cell surface receptors, growth factors or signalling molecules. ... or agonising cell surface receptors. Some of the antibodies generated in the McCafferty Lab have therapeutic potential as anti ? ...

  40. Dr Elisa Laurenti

    ... responses will prove important to design novel therapies against haematopoietic disease. ...

  41. Professor Klaus Okkenhaug

    ... influences different kinds of immune responses including against cancer. Results from these investigations help provide rationale for ...

  42. Miss Morwenna Hall

    ... create potential drug targets to eventually use clinically against certain types of cancers.  ...

  43. Dr taufiq rahman

    rational development of small molecule leads against oncoproteins; development of small molecule inhibitors of ...

  44. Dr Tim Mitchell

    ... SKIL® can also generate drug research programmes against other kinase targets. ...

  45. Professor Tony Kouzarides

    ... molecule inhibitor I-BET has been shown to be effective against epigenetic pathways leading to MLL-leukaemia. This I-BET compound is ...

  46. Dr Ahsan MEMON

    Ahsan has developed a sui generis versatile holographic system capable of diverse photo-perturbation techniques including photo-manipulation, photo-activation, photo-ablation, optical-trapping and optogenetics, combined with multi-modal imaging...

  47. Professor Florian Markowetz

    ... work combines two complementary directions by (1) analyzing global portraits of cancer and (2) modeling key mechanisms and their response ...

  48. Professor Jasmin Fisher

    ... an executable model has been built, it can be used to get a global dynamic picture of how the system responds to various perturbations. In ...

  49. Dr K Gatley

    Randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients, aged 11-45 years, with intermediate and poor-risk metastatic germ cell tumours. The aim of the trial is to compare the two treatment arms with respect to: ...

  50. Dr Kevin Chalut

    ... of stem cell states. I have also been finding links between global epigenetic states and cell/nuclear mechanics, and am studying how these ...

  51. Dr Kenneth Seamon

    Director of Scientific Development and Global Collaborations ...

  52. Dr Namshik Han

    ... and to develop new computational methods fulfilling the global mission of identifying new or better therapies from the analysis of ...

  53. Professor Rebecca Fitzgerald

    Oesophageal cancer is a global health problem. The work of my laboratory and clinical team is driven by ...

  54. Dr Amos Burke

    Dr Amos Burke is a childhood cancer specialist working at Addenbrooke's providing a service for chidlren in the East of England. He has a particular interest in childhood lymphomas and is a member of the National Cancer Research Institute Lymphoma...

  55. Dr Anna Piskorz

    ... The translational research I’m involved in requires close collaboration with Addenbrook’s hospital and Cancer Molecular Diagnostic ...

  56. Dr Alex Samoshkin

    I have been a Translational Technology Manager in the University of Cambridge since 2017. My primary role is to connect researchers in technology/physical sciences with clinicians and academics to develop new collaborative translational projects. I...

  57. Professor Ben Simons

    ... malignant tissue. These investigations are pursued in close collaboration with experimentalists in Cambridge. ...

  58. Professor Sir David Klenerman

    ... the T-cell receptor on live cells and protein folding. In collaboration with Professor Dobson we are also probing the early stages of the ...

  59. Dr Giulia Emanuelli

    ... strategies for the treatment of mesothelioma. We work in collaboration with Mesobank, the largest UK-based mesothelioma biobank, and the ...

  60. Professor Grant Stewart

    ... above goals, Grant coordinates the Cambridge Renal Cancer Collaboration (CamRenCan) a group of over 40 clinicians, translational ... Cancer Group. Grant developed and co-directs the Scottish Collaboration On Translational Research into Renal Cell Cancer (SCOTRRCC), a ...

  61. Dr Giovanna Zinzalla

    HOW TRANSCRIPTIONAL REGULATORS CONTROL GENE EXPRESSION PROGRAMS AND CELL FATE IN NORMAL AND MALIGNANT CELLS How the transcriptional machinery orchestrates gene expression programs during development, renewal and in response to environmental...

  62. Dr James Hadfield

    ... capabilities and via external academic or commercial collaboration and partnering opportunities. Success for me in Translational ...

  63. Dr Sarah Jefferies

    ... provision I am a collaborator in an industry-academic-NHS collaboration developing hyperpolarized pyruvate/lactate 13C-MR imaging and ...

Pages